VA launches trial of GLP-1 drugs to treat alcohol use disorder in veterans

The VA is launching a new clinical trial to test whether blockbuster GLP-1 drugs used for weight loss and type 2 diabetes can treat alcohol use disorder in veterans.

Midlife TV binging linked to smaller brain structures, especially in men

The study found that the key parts of the brains of people who told researchers they watched TV "very often" during their midlife years were found to have smaller structures.

Kentucky family awarded record settlement against gun dealer

A ghost gun organization has been ordered to pay more than $100 million to a Kentucky family after the death of a teenager who bought a pistol-building kit online from the company.

Blood test could help identify people at high risk for Alzheimer's, study suggests

A blood test may help predict whether healthy older adults are likely to develop Alzheimer’s symptoms within five to 10 years, researchers reported Wednesday.

Tylenol autism lawsuits revived by federal appeals court

A federal appeals court has revived more than 500 lawsuits against Tylenol maker Kenvue, ruling that a lower court improperly excluded expert testimony in cases.

US to award more than $281 million for mental health programs

In a sweeping effort to combat the nation's ongoing mental health crisis, officials announced a massive financial investment aimed at bolstering support networks for programs including substance abuse and mental illness.

Late Dallas Cowboys DE Marshawn Kneeland diagnosed with CTE

Researchers at Boston University diagnosed former Dallas Cowboys defensive end Marshawn Kneeland with Stage 1 CTE following his death by suicide in North Texas last November.

Four states want Meta to pay $1.4 trillion in youth addiction case

Four states are demanding $1.4 trillion from Meta over claims that the social media giant deliberately created and marketed Facebook and Instagram to underage users, while failing to warn parents or children about the alleged harms of the social media platform’s addiction.

9/11 responders with PTSD face higher risk of accelerated aging, research suggests

A new study found responders with PTSD who were dispatched to the 9/11 terror attacks in 2001, showed signs of faster biological aging and a higher risk of chronic disease.

New LSD-based drug eases depression symptoms in late-stage trial

The latest LSD-based drug was used in a clinical trial to support patients with major depression in an initial step in bringing the drug closer to Food and Drug Administration submission and review.

Beltline murder suspect had prior convictions

The suspect in the fatal Atlanta Beltline stabbing has been identified as Jahmare Brown, a man with prior misdemeanor convictions.

How Fayette County is using a $1,000 building to fight substance abuse

Fayette County officials opened a new permanent home for the county's accountability court programs to provide therapy and support services.

Facebook, Instagram could shutdown in New Mexico over child safety dispute

Meta may consider pulling its social media services from New Mexico as state prosecutors intensify their push for reforms to the tech company's platforms.

Trump fast-tracks review of psychedelic drugs to treat depression, PTSD

President Trump signed an executive order to fast-track the study of using psychedelic drugs to treat Americans – especially veterans – living with depression, PTSD and other conditions.

Emory and Georgia Tech trial helps paralyzed patients speak

Researchers at Emory and Georgia Tech are using brain-computer interfaces to help paralyzed patients speak.